Siponimod offers hope for people with secondary progressive MS, in which disabilities get worse over time

A new drug for multiple sclerosis could slow the progression of symptoms of a form of the disease for which effective treatments have proved elusive, research suggests.

It is thought about 100,000 people in the UK and 2,500,000 people worldwide have MS, a neurological condition that can affect speech, movement of limbs and vision, among other things.

Continue reading…

Read More New MS drug could slow symptoms of ‘untreatable’ form of disease

Facebook Comments